These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35967878)

  • 61. Combination therapy with benznidazole and doxycycline shows no additive effect to monotherapy with benznidazole in mice infected with the VL-10 strain of the Trypanosoma cruzi.
    Carneiro ACA; Costa GP; Ferreira CS; Ramos IPR; Sarandy MM; Leite ALJ; Menezes APJ; Silva BM; Nogueira KOPC; Carvalho ACC; Gonçalves RV; Talvani A
    Int J Cardiol; 2020 Jan; 299():243-248. PubMed ID: 31353153
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
    Francisco AF; de Abreu Vieira PM; Arantes JM; Pedrosa ML; Martins HR; Silva M; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
    Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gene expression study using real-time PCR identifies an NTR gene as a major marker of resistance to benzonidazole in Trypanosoma cruzi.
    Mejía-Jaramillo AM; Fernández GJ; Palacio L; Triana-Chávez O
    Parasit Vectors; 2011 Sep; 4():169. PubMed ID: 21892937
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069.
    Sayé M; Gauna L; Valera-Vera E; Reigada C; Miranda MR; Pereira CA
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007481. PubMed ID: 31961864
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro trypanocidal activity of tetraethylthiuram disulfide and sodium diethylamine-N-carbodithioate on Trypanosoma cruzi.
    Lane JE; Ribeiro-Rodrigues R; Suarez CC; Bogitsh BJ; Jones MM; Singh PK; Carter CE
    Am J Trop Med Hyg; 1996 Sep; 55(3):263-6. PubMed ID: 8842112
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mapping benznidazole resistance in trypanosomatids and exploring evolutionary histories of nitroreductases and ABCG transporter protein sequences.
    Petravicius PO; Costa-Martins AG; Silva MN; Reis-Cunha JL; Bartholomeu DC; Teixeira MMG; Zingales B
    Acta Trop; 2019 Dec; 200():105161. PubMed ID: 31494121
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trypanosoma cruzi infection and benznidazole therapy independently stimulate oxidative status and structural pathological remodeling of the liver tissue in mice.
    Novaes RD; Santos EC; Cupertino MC; Bastos DS; Oliveira JM; Carvalho TV; Neves MM; Oliveira LL; Talvani A
    Parasitol Res; 2015 Aug; 114(8):2873-81. PubMed ID: 25912691
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Repurposing strategies for Chagas disease therapy: the effect of imatinib and derivatives against Trypanosoma cruzi.
    Simões-Silva MR; De Araújo JS; Peres RB; Da Silva PB; Batista MM; De Azevedo LD; Bastos MM; Bahia MT; Boechat N; Soeiro MNC
    Parasitology; 2019 Jul; 146(8):1006-1012. PubMed ID: 30859917
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Benznidazole self-emulsifying delivery system: A novel alternative dosage form for Chagas disease treatment.
    Mazzeti AL; Oliveira LT; Gonçalves KR; Schaun GC; Mosqueira VCF; Bahia MT
    Eur J Pharm Sci; 2020 Mar; 145():105234. PubMed ID: 31978590
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The immunomodulatory effects of the Enalapril in combination with Benznidazole during acute and chronic phases of the experimental infection with Trypanosoma cruzi.
    Leite ALJ; Paula Costa G; Lopes LR; Reis Mota LWD; Vieira PMA; Talvani A
    Acta Trop; 2017 Oct; 174():136-145. PubMed ID: 28720491
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Changes of RAPD profile of Trypanosoma cruzi II with Canova and Benznidazole.
    Aleixo DL; Ferraz FN; de Melo CS; Gomes ML; Toledo MJ; Kaneshima EN; Bersani-Amado CA; Araújo SM
    Homeopathy; 2008 Apr; 97(2):59-64. PubMed ID: 18439965
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Activities of psilostachyin A and cynaropicrin against Trypanosoma cruzi in vitro and in vivo.
    da Silva CF; Batista Dda G; De Araújo JS; Batista MM; Lionel J; de Souza EM; Hammer ER; da Silva PB; De Mieri M; Adams M; Zimmermann S; Hamburger M; Brun R; Schühly W; Soeiro Mde N
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5307-14. PubMed ID: 23939901
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
    Santos DM; Martins TA; Caldas IS; Diniz LF; Machado-Coelho GL; Carneiro CM; Oliveira Rde P; Talvani A; Lana M; Bahia MT
    Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Organometallic Gold(III) Complex [Au(Hdamp)(L1
    Lopes CD; Possato B; Gaspari APS; Oliveira RJ; Abram U; Almeida JPA; Rocho FDR; Leitão A; Montanari CA; Maia PIS; da Silva JS; de Albuquerque S; Carneiro ZA
    ACS Infect Dis; 2019 Oct; 5(10):1698-1707. PubMed ID: 31419384
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi.
    Saraiva VB; Gibaldi D; Previato JO; Mendonça-Previato L; Bozza MT; Freire-De-Lima CG; Heise N
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3472-7. PubMed ID: 12384352
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: A systematic review and meta-analysis.
    Vela A; Coral-Almeida M; Sereno D; Costales JA; Barnabé C; Brenière SF
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009269. PubMed ID: 33750958
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
    Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ
    Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease.
    Araújo MS; Martins-Filho OA; Pereira ME; Brener Z
    J Antimicrob Chemother; 2000 Jun; 45(6):819-24. PubMed ID: 10837436
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
    Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice.
    Diniz LF; Mazzeti AL; Caldas IS; Ribeiro I; Bahia MT
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.